Evidence map›Paper›PMID 35838898›Full record

ReviewCurrent neurology and neuroscience reports2022

Advances in DBS Technology and Novel Applications: Focus on Movement Disorders.

Sina R Potel, Sara Marceglia, Sara Meoni, Suneil K Kalia, Rubens G Cury, Elena Moro

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2024
    Review
  7. Article
  8. Article
  9. Cross-Frequency Coupling and Intelligent Neuromodulation.Cyborg and bionic systems (Washington, D.C.) · 2023
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Sina R PotelService de Neurologie, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
Sara MarcegliaDipartimento Di Ingegneria E Architettura, Università Degli Studi Di Trieste, Trieste, Italy.
Sara MeoniService de Neurologie, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
Suneil K KaliaDivision of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.
Rubens G CuryDepartment of Neurology, Movement Disorders Center, School of Medicine, University of São Paulo, São Paulo, Brazil.
Elena MoroService de Neurologie, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France. emoro@chu-grenoble.fr.
Centre Hospitalier Universitaire de Grenoble · FRInserm · FRUniversidade de São Paulo · BRUniversité Grenoble Alpes · FRUniversity of Toronto · CAUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDeep brain stimulation (DBS) is an established treatment in several movement disorders, including Parkinson's disease, dystonia, tremor, and Tourette syndrome. In this review, we will review and discuss the most recent findings including but not limited to clinical evidence. RECENT

findingsNew DBS technologies include novel hardware design (electrodes, cables, implanted pulse generators) enabling new stimulation patterns and adaptive DBS which delivers potential stimulation tailored to moment-to-moment changes in the patient's condition. Better understanding of movement disorders pathophysiology and functional anatomy has been pivotal for studying the effects of DBS on the mesencephalic locomotor region, the nucleus basalis of Meynert, the substantia nigra, and the spinal cord. Eventually, neurosurgical practice has improved with more accurate target visualization or combined targeting. A rising research domain emphasizes bridging neuromodulation and neuroprotection. Recent advances in DBS therapy bring more possibilities to effectively treat people with movement disorders. Future research would focus on improving adaptive DBS, leading more clinical trials on novel targets, and exploring neuromodulation effects on neuroprotection.

Indexed as

Deep Brain StimulationDystoniaMovement DisordersParkinson DiseaseHumansTechnologyTremorBasal gangliaDeep brain stimulationMovement disordersNeuromodulationParkinson’s diseaseTechnological advances

Identifiers

PMID35838898
OpenAlexW4285591280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.